Diaverum UK

What Diaverum UK does

Diaverum UK is the United Kingdom operating entity of Sweden-headquartered Diaverum, a global renal care provider. Founded in the UK in 2007 and headquartered in St. Albans, England, with 124 employees, Diaverum UK delivers outpatient dialysis services to patients with chronic kidney disease, alongside peritoneal dialysis and kidney transplant support. Patient access is driven by referrals from NHS trusts and contracted healthcare providers, positioning the NHS as the dominant referral channel and payer.

The service portfolio combines core clinical renal replacement therapies — haemodialysis at physical clinic locations, peritoneal dialysis as a home-based alternative, and kidney transplant coordination — with differentiated programme layers. These include the d.HOLIDAY travel-dialysis programme, which leverages the parent group's 20+ country clinic network to enable patient mobility, and the d.ACADEMY nurse education programme, re-accredited by EDTNA/ERCA. Sub-brands (d.HOLIDAY, d.ACADEMY, d.HOLIDAY Fly Back Programme) function as patient-experience and workforce-quality differentiators rather than as standalone technology platforms. The company is regulated by the UK Care Quality Commission.

Diaverum UK operates as a wholly-owned regional subsidiary within a privately-held global parent group. Pricing is not publicly disclosed; the unit-economics model relies on NHS commissioning arrangements and (where applicable) private-pay patients. No funding rounds, M&A activity, or revenue figures are disclosed in the available source material, limiting financial visibility. Strategic activity in 2022–2023 has centred on UK clinic expansion (Darlington, 2023), internal clinical-excellence recognition (Lewisham, 2022), and continued buildout of the d.HOLIDAY ecosystem.

Name

Diaverum UK

Legal name

Diaverum

Website

https://diaverum.co.uk

Company type

Private

Operating status

Operating

Short description

Diaverum UK is a CQC-regulated provider of life-enhancing renal care, delivering dialysis, peritoneal dialysis, and transplant support to chronic kidney disease patients in England, primarily through NHS referrals, as the UK subsidiary of global operator Diaverum.

Ownership category

akta.pro rank

Product category

Renal Care Services

NAICS

Kidney Dialysis Centers (621492), Ambulatory Health Care Services (621)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC)

Keywords

• Renal care services
• Dialysis treatment
• Kidney transplantation
• Peritoneal dialysis
• Chronic kidney disease

Headquarters

HQ city

Darlington

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Distribution channels1 record

Marketing channels1 record

Core offering

Diaverum UK provides life-enhancing renal care services to patients with chronic kidney disease in the United Kingdom. Core offerings include peritoneal dialysis (kidney replacement therapy performed inside the body without blood manipulation), kidney transplantation support, and the d.HOLIDAY programme that enables dialysis patients to travel internationally while receiving treatment at partnered clinics, including the Fly Back Programme for transplant recipients.

Product overview

Diaverum UK provides life-enhancing renal care to patients with chronic kidney disease through a portfolio of core treatment services and supporting programmes. The core offerings include peritoneal dialysis (a kidney replacement therapy inside the body without blood manipulation) and kidney transplantation (a surgical treatment option). These are complemented by the d.HOLIDAY travel programme enabling patients to travel worldwide while receiving dialysis, including the Fly Back Programme for transplant patients. Educational support is provided through d.ACADEMY, a nurse education programme accredited by EDTNA/ERCA.

Differentiator

Problem solved

Functional benefit

Brands

• d.HOLIDAY: A travel programme enabling dialysis patients to travel while receiving treatment, with destination specials and newsletter updates for patients on dialysis.
• d.ACADEMY
• d.HOLIDAY Fly Back Programme

Products and services

• d.HOLIDAY A travel programme enabling dialysis patients to live a fulfilling life by travelling internationally while receiving treatment at partnered clinics worldwide. Includes the Fly Back Programme which funds safe and fast returns home for patients who receive their transplant call whilst travelling. Designed for chronic kidney disease patients on dialysis who want to travel.
• Kidney transplant A surgical renal replacement therapy option for patients when kidneys fail. Provided to chronic kidney disease patients as an alternative to dialysis.
• Peritoneal dialysis A kidney replacement therapy that takes place inside the body without any blood manipulation, offering an alternative to haemodialysis for chronic kidney disease patients.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Fresenius Medical Care: Global leader in dialysis products and dialysis care services, operating the largest worldwide network of dialysis clinics. Directly competes with Diaverum UK in providing haemodialysis, peritoneal dialysis, and related renal care services to NHS and private patients in the UK.
• DaVita: One of the two largest global dialysis services operators, with significant UK clinic presence. Competes head-to-head with Diaverum UK for NHS dialysis contracts and patient referrals, offering the same core haemodialysis and peritoneal dialysis modalities.
• B. Braun Avitum: Operates a network of renal care centres across Europe and other regions as part of the B. Braun medical group. Directly comparable to Diaverum UK in delivering chronic haemodialysis, peritoneal dialysis, and apheresis services, including within UK and European markets.
• Renal Services (UK): UK-focused independent dialysis provider operating haemodialysis clinics in partnership with NHS trusts. Closely comparable to Diaverum UK in scope, NHS-referral model, and service mix, serving chronic kidney disease patients in the UK market.
• InHealth Group: UK-based independent healthcare provider offering a range of community and specialty services, including diagnostic and chronic disease management for the NHS. Competes with Diaverum UK in providing outsourced NHS-funded specialty care services, including adjacent renal pathways.

Others

• Diaverum (parent): The Swedish-based global parent entity of Diaverum UK, operating clinics in 20+ countries. Included as a reference point for the UK entity's strategic and operational context rather than as an external comparable.
• Diaverum Middle East / Saudi Arabia: Other regional entities under the same Diaverum parent brand operating in adjacent geographies. Included for reference as the global network supporting the UK entity, not as an external peer.

Emerging players

• Satellite Healthcare: US-based non-profit dialysis services provider focused on chronic haemodialysis and peritoneal dialysis. Comparable in service mix to Diaverum UK but operates in a different (US) regulatory and reimbursement environment, providing useful cross-market reference points for dialysis operating models.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks4 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diaverum UK